Synthesis and in vitro characterization of oxytocin receptor targeted PEGylated immunoliposomes for drug delivery to the uterus

References

• Anderson, M. and Omri, A., 2004. The effect of different lipid components on the in vitro stability and release kinetics of liposome formulations. Drug delivery, 11 (1), 33–39.
   PubMed Web of Science ®Google Scholar
• Arrowsmith, S., Kendrick, A., and Wray, S., 2010. Drugs acting on the pregnant uterus. Obstetrics, gynaecology and reproductive medicine, 20 (8), 241–247.
   PubMedGoogle Scholar
• Arrowsmith, S. and Wray, S., 2014. Oxytocin: its mechanism of action and receptor signalling in the myometrium. Journal of neuroendocrinology, 26 (6), 356–369.
   PubMed Web of Science ®Google Scholar
• Busnelli, M., et al., 2010. Oxytocin-induced cell growth proliferation in human myometrial cells and leiomyomas. Fertility and sterility, 94 (5), 1869–1874.
   PubMed Web of Science ®Google Scholar
• Butwick, A.J., et al., 2015. Second-line uterotonics and the risk of hemorrhage-related morbidity. American journal of obstetrics and gynecology, 212, 642 e1–642 e7.
   Web of Science ®Google Scholar
• De Heus, R., et al., 2009. Adverse drug reactions to tocolytic treatment for preterm labour: prospective cohort study. BMJ, 338 (2), b744.
   PubMedGoogle Scholar
• Everts, M., et al., 2003. In vitro cellular handling and in vivo targeting of E-selectin-directed immunoconjugates and immunoliposomes used for drug delivery to inflamed endothelium. Pharmaceutical research, 20 (1), 64–72.
   PubMed Web of Science ®Google Scholar
• Fuchs, A.R., et al., 1984. Oxytocin receptors in the human uterus during pregnancy and parturition. American journal of obstetrics and gynecology, 150 (6), 734–741.
   PubMed Web of Science ®Google Scholar
• Gimpl, G., et al., 2000. Oxytocin receptors and cholesterol: interaction and regulation. Experimental physiology, 85 Spec No (Spec No), 41S–49S.
   PubMedGoogle Scholar
• Gimpl, G. and Fahrenholz, F., 2000. Human oxytocin receptors in cholesterol-rich vs. cholesterol-poor microdomains of the plasma membrane. European journal of biochemistry, 267 (9), 2483–2497.
   PubMedGoogle Scholar
• Gimpl, G. and Fahrenholz, F., 2001. The oxytocin receptor system: structure, function, and regulation. Physiological reviews, 81 (2), 629–683.
   PubMed Web of Science ®Google Scholar
• Haas, D.M., et al., 2012. Tocolytic therapy for preterm delivery: systematic review and network meta-analysis. British medical journal (clinical research ed.), 345, e6226.
   PubMed Web of Science ®Google Scholar
• Hua, S. and Cabot, P.J., 2013. Targeted nanoparticles that mimic immune cells in pain control inducing analgesic and anti-inflammatory actions: a potential novel treatment of acute and chronic pain condition. Pain physician, 16, E199–E216.
   PubMed Web of Science ®Google Scholar
• Hua, S., et al., 2011. Targeting of ICAM-1-directed immunoliposomes specifically to activated endothelial cells with low cellular uptake: use of an optimized procedure for the coupling of low concentrations of antibody to liposomes. Journal of liposome research, 21 (2), 95–105.
   PubMed Web of Science ®Google Scholar
• Jeng, Y.J., et al., 2003. Regulation of oxytocin receptor expression in cultured human myometrial cells by fetal bovine serum and lysophospholipids. Endocrinology, 144 (1), 61–68.
   PubMed Web of Science ®Google Scholar
• Jorgensen, J.S., Weile, L.K., and Lamont, R.F., 2014. Preterm labour: current tocolytic options for the treatment of preterm labour. Expert opinion on pharmacotherapy, 15, 585–588.
   PubMed Web of Science ®Google Scholar
• Kessner, S., et al., 2001. Investigation of the cellular uptake of E-Selectin-targeted immunoliposomes by activated human endothelial cells. Biochimica et biophysica acta, 1514 (2), 177–190.
   PubMed Web of Science ®Google Scholar
• Kuhn, D.A., et al., 2014. Different endocytotic uptake mechanisms for nanoparticles in epithelial cells and macrophages. Beilstein journal of nanotechnology, 5, 1625–1636.
   PubMed Web of Science ®Google Scholar
• Lopes de Menezes, D.E., Pilarski, L.M., and Allen, T.M., 1998. In vitro and in vivo targeting of immunoliposomal doxorubicin to human B-cell lymphoma. Cancer research, 58 (15), 3320–3330.
   PubMed Web of Science ®Google Scholar
• Maggi, M., et al., 1996. Interferon-alpha downregulates expression of the oxytocin receptor in cultured human myometrial cells. American journal of physiology, 271, E840–E846.
   PubMedGoogle Scholar
• Molnar, M., et al., 1999. Oxytocin activates mitogen-activated protein kinase and up-regulates cyclooxygenase-2 and prostaglandin production in human myometrial cells. American journal of obstetrics and gynecology, 181, 42–49.
   PubMed Web of Science ®Google Scholar
• Mousa, HA., et al., Z., 2014. Treatment for primary postpartum haemorrhage. Cochrane database of systematic reviews, Issue 2, CD003249.
   Google Scholar
• Nehoff, H., et al., 2014. Nanomedicine for drug targeting: strategies beyond the enhanced permeability and retention effect. International journal of nanomedicine, 9, 2539–2555.
   PubMed Web of Science ®Google Scholar
• Norman, J.E., et al., 2007. Inflammatory pathways in the mechanism of parturition. BMC pregnancy and childbirth, 7 Suppl 1 (Suppl 1), S7.
   PubMedGoogle Scholar
• Oakley, R.H., et al., 2001. Molecular determinants underlying the formation of stable intracellular G protein-coupled receptor-beta-arrestin complexes after receptor endocytosis. The journal of biological chemistry, 276 (22), 19452–19460.
   PubMed Web of Science ®Google Scholar
• Ohmichi, M., et al., 1995. Oxytocin stimulates mitogen-activated protein kinase activity in cultured human puerperal uterine myometrial cells. Endocrinology, 136 (5), 2082–2087.
   PubMed Web of Science ®Google Scholar
• Paul, J.W., et al., 2017. Drug delivery to the human and mouse uterus using immunoliposomes targeted to the oxytocin receptor. American journal of obstetrics and gynecology, 216, 283 e1–283 e14.
   PubMed Web of Science ®Google Scholar
• Phaneuf, S., et al., 1993. Oxytocin-stimulated phosphoinositide hydrolysis in human myometrial cells: involvement of pertussis toxin-sensitive and -insensitive G-proteins. Journal of endocrinology, 136 (3), 497–509.
   PubMed Web of Science ®Google Scholar
• Sawant, R.R. and Torchilin, V.P., 2012. Challenges in development of targeted liposomal therapeutics. The aaps journal, 14 (2), 303–315.
   PubMed Web of Science ®Google Scholar
• Sercombe, L., et al., 2015. Advances and challenges of liposome assisted drug delivery. Frontiers in pharmacology, 6, 286.
   PubMed Web of Science ®Google Scholar
• Sharkey, J. and Olcese, J., 2007. Transcriptional inhibition of oxytocin receptor expression in human myometrial cells by melatonin involves protein kinase C signaling. The journal of clinical endocrinology and metabolism, 92 (10), 4015–4019.
   PubMed Web of Science ®Google Scholar
• Soloff, M.S., Alexandrova, M., and Fernstrom, M.J., 1979. Oxytocin receptors: triggers for parturition and lactation?. Science (New York), 204 (4399), 1313–1315.
   Google Scholar
• Soloff, M.S., et al., 2004. Immortalization and characterization of human myometrial cells from term-pregnant patients using a telomerase expression vector. Molecular human reproduction, 10 (9), 685–695.
   PubMed Web of Science ®Google Scholar
• Szukiewicz, D., et al., 2015. Myometrial contractility influences oxytocin receptor (OXTR) expression in term trophoblast cells obtained from the maternal surface of the human placenta. BMC pregnancy childbirth, 15, 220.
   PubMed Web of Science ®Google Scholar
• Tahara, A., et al., 2000. Pharmacologic characterization of the oxytocin receptor in human uterine smooth muscle cells. British journal of pharmacology, 129 (1), 131–139.
   PubMed Web of Science ®Google Scholar
• Ulrich, A.S., 2002. Biophysical aspects of using liposomes as delivery vehicles. Bioscience reports, 22 (2), 129–150.
   PubMed Web of Science ®Google Scholar
• Voinea, M., et al., 2005. Immunoliposomes directed toward VCAM-1 interact specifically with activated endothelial cells–a potential tool for specific drug delivery. Pharmaceutical research, 22 (11), 1906–1917.
   PubMed Web of Science ®Google Scholar
• Wathes, D.C., et al., 1999. Oxytocin receptor expression in human term and preterm gestational tissues prior to and following the onset of labour. Journal of endocrinology, 161 (1), 143–151.
   PubMed Web of Science ®Google Scholar
• Zingg, H.H. and Laporte, S.A., 2003. The oxytocin receptor. Trends in endocrinology and metabolism, 14 (5), 222–227.
   PubMed Web of Science ®Google Scholar